ArticleJournal of clinical medicine2024

Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study.

Marco Galluzzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.